APYX Apyx Medical Corp

$4.10 -2.03%

Healthcare · Surgical & Medical Instruments & Apparatus

Apyx Medical Corp (APYX) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $172 million. Shares last traded at $4.10, 18.5% below their 52-week high. Over the past year the stock is up 125.9%. Net profit margin is -21.2%, below the peer median of -7.6%. Revenue grew 9.9% year over year.

Market Cap

$172M

Shares Out

41.9M

EPS (TTM)

$-1.02

P/E Ratio

—

P/S Ratio

3.25

P/B Ratio

13.38

Dividend / Share

—

Dividend Yield

—

52-Week High

$5.03

52-Week Low

$1.63

Volume

2,406

Avg Vol (3m)

8,136.095

Performance

-11.64%

+4.86%

+15.82%

+9.92%

YTD

+17.14%

+125.90%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

47.68

SMA (50)

$3.94

SMA (200)

$3.54

Price vs SMA50

+3.94%

Price vs SMA200

+15.68%

ATR (14)

$0.29

Financials

Revenue

$53M

Net Income

$-11M

Gross Margin

62.5%

Operating Margin

-12.2%

Net Margin

-21.2%

Return on Equity

-87.4%

Return on Assets

-17.8%

Current Ratio

5.80

Debt / Equity

2.92

Revenue Growth (YoY)

+9.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q2 2024	$-0.41	2024-08-08
Q1 2024	$-0.22	2024-05-09
FY 2023	$-0.54	2024-03-21
Q3 2023	$-0.26	2023-11-09
Q2 2024	$-0.13	2024-08-08
Q1 2024	$-0.10	2024-05-09

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

APYX vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

3.25 / 2.52 med

+29% premium

Net margin vs peers

-21.2% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.